Efficacy of fecal microbiota transplantation for patients with irritable bowel syndrome at three years after transplantation

The long-term efficacy and possible adverse events of fecal microbiota transplantation (FMT) for IBS are unknown. This study performed a 3-year follow-up of the patients in our previous clinical trial to clarify these aspects.

This entry was posted in News. Bookmark the permalink.